These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11280506)

  • 1. Adsorption of erythropoietin and growth hormone to peritoneal dialysis bags and tubing.
    Schröder CH; Swinkels LM; Reddingius RE; Sweep FG; Willems HL; Monnens LA
    Perit Dial Int; 2001; 21(1):90-2. PubMed ID: 11280506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of the bioavailability of intraperitoneal erythropoietin in children on peritoneal dialysis by administration in small dialysis bags.
    Reddingius RE; de Boer AW; Schröder CH; Willems JL; Monnens LA
    Perit Dial Int; 1997; 17(5):467-70. PubMed ID: 9358528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin and peritoneal dialysis: the efficacy of intraperitoneal dosing.
    Nissenson AR
    Perit Dial Int; 1992; 12(4):350-2. PubMed ID: 1420491
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis.
    Reddingius RE; Schröder CH; Koster AM; Monnens LA
    Eur J Pediatr; 1994 Nov; 153(11):850-4. PubMed ID: 7843202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1 alpha-Hydroxycholecalciferol adsorption to peritoneal dialysis bags: influence of time, glucose concentration, temperature, and albumin.
    Joffe P; Ladefoged SD; Cintin C; Lehmann H
    Nephrol Dial Transplant; 1992; 7(12):1249-51. PubMed ID: 1337168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of intraperitoneal erythropoietin administered undiluted or diluted in dialysate.
    Bargman JM; Jones JE; Petro JM
    Perit Dial Int; 1992; 12(4):369-72. PubMed ID: 1420495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal recombinant human erythropoietin therapy: influence of the duration of continuous ambulatory peritoneal dialysis treatment and peritonitis.
    Huang TP; Lin CY
    Am J Nephrol; 1995; 15(4):312-7. PubMed ID: 7573189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of erythropoietin determination in the dialysate of CAPD patients.
    Struijk DG; Koomen GC; Krediet RT; Arisz L
    Adv Perit Dial; 1990; 6():289-91. PubMed ID: 1982829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Ateshkadi A; Johnson CA; Oxton LL; Hammond TG; Bohenek WS; Zimmerman SW
    Am J Kidney Dis; 1993 Jun; 21(6):635-42. PubMed ID: 8503418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adsorption of insulin to the surface of peritoneal dialysis solution containers.
    Johnson CA; Amidon G; Reichert JE; Porter WR
    Am J Kidney Dis; 1983 Nov; 3(3):224-8. PubMed ID: 6356895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Boelaert JR; Schurgers ML; Matthys EG; Belpaire FM; Daneels RF; De Cre MJ; Bogaert MG
    Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Macdougall IC; Roberts DE; Neubert P; Dharmasena AD; Coles GA; Williams JD
    Lancet; 1989 Feb; 1(8635):425-7. PubMed ID: 2563798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF; Chung WW; Leung CB; Chan K; Lai KN
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and dose response after intravenous and subcutaneous administration of recombinant erythropoietin in patients on regular haemodialysis treatment or continuous ambulatory peritoneal dialysis.
    Stockenhuber F; Loibl U; Gottsauner-Wolf M; Jahn C; Manker W; Meisl TF; Balcke P
    Nephron; 1991; 59(3):399-402. PubMed ID: 1758528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritonitis prevented in continuous ambulatory peritoneal dialysis by using the Hong Kong connection.
    Clark RD
    Br Med J (Clin Res Ed); 1984 Feb; 288(6414):353-6. PubMed ID: 6419925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automatic peritoneal dialysis.
    Di Paolo N; Buoncristiani U
    Nephron; 1983; 35(4):248-52. PubMed ID: 6646298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultraviolet light as a sterilising agent for extracorporeal fluid tubing connectors.
    Orange GV; Henderson IS; Leung AC
    Int J Artif Organs; 1985 May; 8(3):125-8. PubMed ID: 4030130
    [No Abstract]   [Full Text] [Related]  

  • 18. Losses of calcitriol to peritoneal dialysis bags and tubing.
    Vieth R; Ledermann SE; Kooh SW; Balfe JW
    Perit Dial Int; 1989; 9(4):277-80. PubMed ID: 2488381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin in patients on peritoneal dialysis.
    Bargman J
    Perit Dial Int; 1989; 9(4):245-6. PubMed ID: 2488375
    [No Abstract]   [Full Text] [Related]  

  • 20. [Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis].
    Marichal JF; Faller B; Mengus C; Wagner JD; Frey G
    Nephrologie; 1985; 6(1):7-10. PubMed ID: 4000380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.